These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1014 related articles for article (PubMed ID: 35337361)

  • 1. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
    Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
    Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.
    Tao XY; Li QQ; Zeng Y
    Mol Cancer; 2024 Jul; 23(1):145. PubMed ID: 39014366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].
    Haupts A; Roth W; Hartmann N
    Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications.
    Shah UJ; Alsulimani A; Ahmad F; Mathkor DM; Alsaieedi A; Harakeh S; Nasiruddin M; Haque S
    Biotechnol Genet Eng Rev; 2022 Oct; 38(2):339-383. PubMed ID: 35968863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
    Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
    J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
    Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
    Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 11. Liquid biopsy in colorectal cancer.
    Najafi S; Majidpoor J; Mortezaee K
    Clin Chim Acta; 2024 Jan; 553():117674. PubMed ID: 38007059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Circulating Tumor DNA in Colorectal Cancer.
    Li H; Lu S; Zhou Z; Zhu X; Shao Y
    Methods Mol Biol; 2023; 2695():227-236. PubMed ID: 37450122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of the Application of Liquid Biopsy in Colorectal Cancer.
    Ding Y; Li W; Wang K; Xu C; Hao M; Ding L
    Biomed Res Int; 2020; 2020():6843180. PubMed ID: 32258135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
    Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
    Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies.
    Debattista J; Grech L; Scerri C; Grech G
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy in ovarian cancer.
    Giannopoulou L; Lianidou ES
    Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.